In:
News
The aim of the meeting was to discuss new developments in scientific and clinical advances to counter hemoglobinopathies, including the mechanisms for new therapeutic targets, curative therapies like gene therapy and genome editing approaches. The meeting also enabled close interactions between clinicians and scientists working in the area towards creating collaborative translational efforts in the area of hemoglobinopathies.
